| 引用本文: | 任磊,葛其南,舒丽芯.加拿大药品特别准入计划对我国同情用药制度的启示[J].中国现代应用药学,2020,37(6):659-663. |
| REN Lei,GE Qinan,SHU Lixin.Enlightenment of Canada’s Drug Special Access Program on China’s Compassionate Use System[J].Chin J Mod Appl Pharm(中国现代应用药学),2020,37(6):659-663. |
|
| 摘要: |
| 目的 在新型冠状病毒肺炎患者没有特效药可用的背景下，为完善我国同情用药制度提供国外可借鉴的经验。方法 通过文献研究等方法对加拿大特别准入计划的具体内容进行研究。结果 加拿大具有相对完善的制度体系，值得我国借鉴。结论 结合我国具体国情，从医师、政府、企业3个维度进行同情用药制度的完善。 |
| 关键词: 加拿大 特别准入计划 同情用药制度 新型冠状病毒肺炎 拓展性用药 |
| DOI：10.13748/j.cnki.issn1007-7693.2020.06.004 |
| 分类号:R951 |
| 基金项目:后勤科研课题（BWS13B099）；后勤科研重点课题（BWS17J020） |
|
| Enlightenment of Canada’s Drug Special Access Program on China’s Compassionate Use System |
|
REN Lei1, GE Qinan2, SHU Lixin3
|
|
1.School of Pharmacy, Naval Medical University, Demonstration Center of Military Medical Supply, Shanghai 200433, China;2.Shanghai Pharmaceutical Association, Shanghai 200040, China;3.School of Pharmacy, Naval Medical University, Department of Military Medical Supply Administration, Shanghai 200433, China
|
| Abstract: |
| OBJECTIVE To provide foreign experience for the improvement of China's compassionate use system under the background that there is no specific medicine for patients with COVID-19. METHODS Studied the specific content of Canada's special access program through literature research methods and so on. RESULTS Canada has a relatively perfect system, which was worthy of our country's reference. CONCLUSION According to the specific national conditions of our country, compassionate use system should be improved from three dimensions:doctor, government and drug manufacturer. |
| Key words: Canada special access program compassionate use system COVID-19 expanded access to investigational drug |
